-cycloaddition of a triyne, which affords an angularly substituted tetracycle. Oxidation of this core gives the typical structure of angucyclinone antibiotics.
The angucyclines are a large class of antibiotics isolated from several strains of Streptomyces. They display a broad spectrum of biological properties including antiviral, antifungal, antitumor, and enzyme inhibitor activity. 1 Most of these antibiotics feature a unique benz[a]anthraquinone structure either with or without a 9-C-glycosidic moiety. Members of this class of angucyclines without a glycosidic moiety, the angucyclinones, have the benz[a]anthraquinone structure either without a hydroxy group at C-6 such as (+)-rubiginone B 2 1 2 or with a hydroxy group at C-6 such as (+)-hatomarubigin A 2.
3 Some members of this class feature a tertiary hydroxy group at C-3 such as (-)-tetrangomycin 3 4 and (-)-rabelomycin 4. 5 Most general strategies for the construction of the angucyclinone framework are based on Diels-Alder reaction of a naphthoquinone with a vinylcyclohexene 6 or on biomimetic-type reactions 7 by employing polyketide condensations.
Herein we would like to present the first synthesis of the benz[a]anthraquinone structure of the angucyclinone antibiotics via an intramolecular cobalt-mediated [2+2+2]-cycloaddition 8 of a triyne. The cyclization of triynes is a powerful synthetic method to form several carbon-carbon bonds in one step and provides access to polycyclic systems with a newly formed highly substituted benzene nucleus. We were able to synthesize a triyne-precursor 11 (Scheme 1) which, after cobalt-mediated [2+2+2]-cycloaddition, gave the anthracene structure 13 (Scheme 2). 9 Cyclization experiments with RhCl(PPh 3 ) 3 and RuCl 2 (dCHPh)(PCy 3 ) 2 , which can also promote alkyne trimerization, 10 were not successful in our systems. Two-step oxidation of 13 led then to the angucyclinone core 15.
The amide 6 11 was at first selectively ortho-lithiated with s-BuLi/TMEDA.
12b It was then transmetalated with ZnCl 2 and then CuCN‚2LiCl and allowed to react with (3-bromoprop-1-ynyl)trimethylsilane 5 to give the propynylamide 7.
12c This was directly reduced to benzaldehyde 8 with the DIBAL/BuLi complex. 13 After addition of lithiated 1-TMS-1,7-octadiyne 14 to this aldehyde, the triple bonds of the resulting triyne 9 were deprotected with NH 4 F 15 (deprotection with TBAF in THF led to decomposition of the triyne 9). The hydroxy group was then transformed into its silyl ether 11 with the aid of TBDMSOTf. 16 For the cyclization of 11 we used CpCo(ethene) 2 17 and the commercially available CpCo(CO) 2 . Reaction of 11 with 5% CpCo(ethene) 2 succeeded under mild conditions at low temperature. Surprisingly we observed the loss of the TBDMSO-group with concomitant aromatization to the anthracene 13 (55% yield and 16% isolated starting material). In the case of CpCo(CO) 2 the reaction had been carried out in toluene under reflux and irradiation with a tungsten lamp (66% yield). Oxidation of 13 with the aid of the mild reagent [Ag(Py) 2 ]MnO 4 gave the anthraquinone 14 (63% yield). 18 We have also been trying to oxidize with CrO 3 in AcOH, but these conditions led to decomposition of the anthracene. The introduction of the C-1 carbonyl was achieved by photooxidation, a general method for the angucyclinones developed by Krohn. 19 Exposure of 14 to visible light (tungsten lamp) gave the typical structure 15 of the angucyclinone antibiotics (61% yield).
In conclusion, the angucyclinone framework 15 was synthesized from benzamide 6 in 8 steps and 11% yield overall. This method provides a new access toward the angucyclinone antibiotics, which do not have a hydroxy group at C-6. The stereocenter at C-3 is not involved in the [2+2+2]-cycloaddition, therefore this methodology offers a good strategy for the enantioselective synthesis of this class of antibiotics.
